sglt2 glp-1 news GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Benefits of treatment with SGLT2i

Drugs override the system

The booming GLP-1 market, projected to reach $167bn by 2031, presents compelling opportunities for private equity players to carve out their niche and capture substantial value, despite industry giants Novo Nordisk and Eli Lilly dominating the lions share of the market. Download PDF

Muscles are crucial for strength, mobility, and calorie burning, so its vital to preserve them...

PlexusDx offers compounded semaglutide and tirzepatide options starting as low as $129 per month, with no insurance requirement or membership fees

Glycine (10 mg/mL): An amino acid known for its anti-inflammatory properties and ability to support digestive health, neurotransmission, and tissue repair